HYBRIGENICS SA Patent applications |
Patent application number | Title | Published |
20140371247 | Selective and Reversible Inhibitors of Ubiquitin Specific Protease 7 - The present invention relates to quinazolin-4-one compounds of formula (I′), their process of preparation and uses thereof. These compounds are useful as selective and reversible inhibitors of ubiquitin specific proteases, particularly USP7, for treating e.g. cancer, neurodegenerative diseases, inflammatory disorders and viral infections. | 12-18-2014 |
20130023521 | NOVEL SELECTIVE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS - The present invention concerns the discovery of new selective inhibitors of ubiquitin specific proteases, their process of preparation and their therapeutic use. | 01-24-2013 |
20120015915 | FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D - The present invention provides new formulations of 14-epi-analogues of vitamin D, such as inecalcitol, providing improved absorption profile. | 01-19-2012 |
20120015914 | FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D - The present invention provides new formulations of 14-epi-analogues of vitamin D, such as inecalcitol, providing improved absorption profile. | 01-19-2012 |